Literature DB >> 12042757

Use of qualitative research to analyze patient and clinician decision making in carotid endarterectomy.

Josephine Gibson1.   

Abstract

Carotid endarterectomy (CEA) is a well-established surgical procedure to reduce a patient's risk of stroke by relieving stenosis of the internal carotid artery. However, the operation is not free from risk and may precipitate a fatal or disabling stroke. Attention in the previous literature has focused on clinicians' decisions about CEA and has given almost no consideration of the patient's perspective. This study describes the use of qualitative research techniques to study patients' and surgeons' perceptions of risk, information needs, and decision-making preferences in relation to investigations and treatment for carotid stenosis. Results of a pilot study are discussed in relation to 5 emerging themes: reducing uncertainty, weighing the odds, the chagrin factor, "whose decision," and gains from surgery. The integration of these emerging themes with the literature on CEA is discussed in relation to the future direction of the project.

Entities:  

Mesh:

Year:  2002        PMID: 12042757     DOI: 10.1067/mvn.2002.125224

Source DB:  PubMed          Journal:  J Vasc Nurs        ISSN: 1062-0303


  3 in total

1.  The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie; Nicole C Maronian
Journal:  J Voice       Date:  2006-03-29       Impact factor: 2.009

2.  Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy.

Authors:  Karen K W Wang; Cathy Charles; Nancy M Heddle; Emmy Arnold; Laura Molnar; Donald M Arnold
Journal:  Health Expect       Date:  2012-08-07       Impact factor: 3.377

3.  Impact of Carotid Artery Stenosis on Quality of Life: A Systematic Review.

Authors:  Ahmed Aber; Aoife Howard; Helen Buckley Woods; Georgina Jones; Jonathan Michaels
Journal:  Patient       Date:  2019-04       Impact factor: 3.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.